The Bill & Melinda Gates Foundation is teaming up with pharmaceutical firms Johnson & Johnson, of New Brunswick, N.J., Eli Lilly and Co., of Indianapolis, Novartis AG, of Basel, Switzerland, Pfizer Inc., of New York, and Glaxosmithkline plc, of London, and Last Mile Health and Living Good to increase access to community-based primary health care for nearly 1.7 million people in up to six African countries. The Health Worker Training Initiative is a three-year investment, matched by The Audacious Project, and totals $18 million. In addition to financial contributions, industry partners will contribute disease-specific expertise and experience in the discovery and development of new tools, which will supplement the community health worker models pioneered by Last Mile Health and Living Goods, in partnership with government.
Novelion Therapeutics Inc., of Vancouver, British Columbia, said it implemented its voluntary liquidation, effective Jan. 16.
Pulmatrix Inc., of Lexington, Mass., said it was informed by Nasdaq that it has regained compliance with the minimum $1 bid price requirement for continued listing.
Theralase Technologies Inc., of Toronto, said it won a precedent-setting lawsuit against anonymous internet posters for defamatory comments. The suit was filed due to false and disparaging statements posted online by anonymous individuals on the www.stockhouse.com bullboard from late 2014 through 2018.